2018
DOI: 10.1590/1677-5449.010817
|View full text |Cite
|
Sign up to set email alerts
|

Profilaxia do tromboembolismo venoso em viagens aéreas

Abstract: Resumo A aviação civil vem apresentando aumento progressivo do número de voos regulares nos últimos 10 anos e, em função disso, mais passageiros estão sendo transportados em viagens aéreas (VAs). Associado a isso, há um aumento das doenças relacionadas às VAs, especialmente naquelas de longa duração. Uma das complicações mais temidas dos voos é o tromboembolismo venoso (TEV), mas a sua real incidência é de difícil mensuração devido à falta de consenso sobre, por exemplo, quanto tempo após o pouso podemos cons… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(7 citation statements)
references
References 15 publications
(50 reference statements)
0
6
0
Order By: Relevance
“…No consensus has been reached in regards to pharmacologic prophylaxis, and this should be prescribed on a case-by-case basis. Antiplatelets did not prove to be an effective prophylactic agent for primary or secondary long-haul flight-related VTE 309,315 , cited in 313,316 ; cited in 317 . While the LONFIT-3 study suggested that the risk of VTE could be eliminated by taking low-molecular-weight heparin (LMWH), there is still a lack of evidence supporting its widespread use in this situation 315,318 , cited in 313 .…”
Section: - Are Patients Who Traveled On Airplanes or Had Long Car Rid...mentioning
confidence: 99%
See 2 more Smart Citations
“…No consensus has been reached in regards to pharmacologic prophylaxis, and this should be prescribed on a case-by-case basis. Antiplatelets did not prove to be an effective prophylactic agent for primary or secondary long-haul flight-related VTE 309,315 , cited in 313,316 ; cited in 317 . While the LONFIT-3 study suggested that the risk of VTE could be eliminated by taking low-molecular-weight heparin (LMWH), there is still a lack of evidence supporting its widespread use in this situation 315,318 , cited in 313 .…”
Section: - Are Patients Who Traveled On Airplanes or Had Long Car Rid...mentioning
confidence: 99%
“…Antiplatelets did not prove to be an effective prophylactic agent for primary or secondary long-haul flight-related VTE 309,315 , cited in 313,316 ; cited in 317 . While the LONFIT-3 study suggested that the risk of VTE could be eliminated by taking low-molecular-weight heparin (LMWH), there is still a lack of evidence supporting its widespread use in this situation 315,318 , cited in 313 . Direct-oral anticoagulants (DOAC) have theoretical benefits given their short half-lives, rapid onset of action and oral administration.…”
Section: - Are Patients Who Traveled On Airplanes or Had Long Car Rid...mentioning
confidence: 99%
See 1 more Smart Citation
“…The texts were based on scientific articles published on PubMed ® and Scientific Electronic Library Online (SciELO) databases, from 2014 to 2018. (19)(20)(21)(22)(23) The non-systematized search was performed using the terms "tromboembolismo venoso" and "venous thromboembolism", in the fields "title or abstract". Studies addressing the definition of the disease, signs and symptoms, risk factors and preventive measures were selected.…”
Section: First Stage: Preparation Of the Manualmentioning
confidence: 99%
“…Studies show that 3.8 billion people travel by air annually and that 300 million of them take longduration flights, [1][2][3] thereby increasing the risk of diseases associated with flights lasting more than 3 hours, the most important of which are deep venous thrombosis (DVT) and pulmonary thromboembolism (PTE). 4 Both DVT and PTE are part of the spectrum of a single disease: venous thromboembolism (VTE). DVT primarily occurs in the lower limbs, caused by coagula that form in the deep vein system.…”
Section: Introductionmentioning
confidence: 99%